Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1114443810 | 11144438 | 10 | F | 201502 | 20160914 | 20150526 | 20160916 | EXP | US-PFIZER INC-2015171612 | PFIZER | 69.00 | YR | F | Y | 77.00000 | KG | 20160916 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1114443810 | 11144438 | 1 | PS | AROMASIN | EXEMESTANE | 1 | Oral | 25 MG, 1X/DAY | X270F | 20753 | 25 | MG | COATED TABLET | QD | |||||
| 1114443810 | 11144438 | 2 | SS | AROMASIN | EXEMESTANE | 1 | Oral | 25 MG, 1X/DAY | Z911P | 20753 | 25 | MG | COATED TABLET | QD | |||||
| 1114443810 | 11144438 | 3 | SS | AROMASIN | EXEMESTANE | 1 | UNK | 20753 | COATED TABLET | ||||||||||
| 1114443810 | 11144438 | 4 | SS | AROMASIN | EXEMESTANE | 1 | Oral | 25 MG, 1X/DAY | 20753 | 25 | MG | COATED TABLET | QD | ||||||
| 1114443810 | 11144438 | 5 | SS | AROMASIN | EXEMESTANE | 1 | Oral | 25 MG, DAILY | Z911P | 20753 | 25 | MG | COATED TABLET | ||||||
| 1114443810 | 11144438 | 6 | C | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | ACETAMINOPHENDIPHENHYDRAMINE HYDROCHLORIDE | 1 | ACETAMINOPHEN 500/DIPHENHYDRAMINE 25 DAILY , DAILY | 0 | |||||||||||
| 1114443810 | 11144438 | 7 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 75 UG, 1X/DAY | 0 | 75 | UG | QD | ||||||||
| 1114443810 | 11144438 | 8 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 20 MG, 1X/DAY | 0 | 20 | MG | QD | ||||||||
| 1114443810 | 11144438 | 9 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 5000 IU, 1X/DAY | 0 | 5000 | IU | CAPSULE | QD | |||||||
| 1114443810 | 11144438 | 10 | C | CALCIUM | CALCIUM | 1 | 1200 MG, 2X/DAY | 0 | 1200 | MG | BID | ||||||||
| 1114443810 | 11144438 | 11 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 2 DF, TWO PILLS TO BE 800 | 0 | 2 | DF | |||||||||
| 1114443810 | 11144438 | 12 | C | COQ10 | UBIDECARENONE | 1 | 100 MG, 1X/DAY | 0 | 100 | MG | QD | ||||||||
| 1114443810 | 11144438 | 13 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | 400, 2X/DAY | 0 | CAPSULE, SOFT | BID | |||||||||
| 1114443810 | 11144438 | 14 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | 1000 IU, 1X/DAY | 0 | 1000 | IU | CAPSULE, SOFT | QD | |||||||
| 1114443810 | 11144438 | 15 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 1000 UG, 1X/DAY | 0 | 1000 | UG | QD | ||||||||
| 1114443810 | 11144438 | 16 | C | IBUPROFEN. | IBUPROFEN | 1 | AS NEEDED | 0 | |||||||||||
| 1114443810 | 11144438 | 17 | C | INSTAFLEX | DIETARY SUPPLEMENT | 1 | UNK | 0 | |||||||||||
| 1114443810 | 11144438 | 18 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK | 0 | |||||||||||
| 1114443810 | 11144438 | 19 | C | BUPROPION HCL | BUPROPION HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 1114443810 | 11144438 | 20 | C | XANAX | ALPRAZOLAM | 1 | 0.25 MG, 1X/DAY AT NIGHT | 0 | .25 | MG | QD | ||||||||
| 1114443810 | 11144438 | 21 | C | LYSINE | LYSINE | 1 | UNK, (ONCE IN A WHILE) | 0 | |||||||||||
| 1114443810 | 11144438 | 22 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | UNK | 0 | |||||||||||
| 1114443810 | 11144438 | 23 | C | Coral Calcium Supreme | 2 | 400 MG, DAILY | 0 | 400 | MG | CAPSULE, SOFT |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 1114443810 | 11144438 | 1 | Breast cancer female |
| 1114443810 | 11144438 | 2 | Hormone level abnormal |
| 1114443810 | 11144438 | 6 | Insomnia |
| 1114443810 | 11144438 | 9 | Hypovitaminosis |
| 1114443810 | 11144438 | 13 | Vitamin E deficiency |
| 1114443810 | 11144438 | 15 | Asthenia |
| 1114443810 | 11144438 | 17 | Arthropathy |
| 1114443810 | 11144438 | 20 | Sleep disorder |
| 1114443810 | 11144438 | 21 | Oral herpes |
| 1114443810 | 11144438 | 23 | Osteoporosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 1114443810 | 11144438 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 1114443810 | 11144438 | Back pain | |
| 1114443810 | 11144438 | Bronchitis | |
| 1114443810 | 11144438 | Chest discomfort | |
| 1114443810 | 11144438 | Chest pain | |
| 1114443810 | 11144438 | Cough | |
| 1114443810 | 11144438 | Dyspnoea | |
| 1114443810 | 11144438 | Fall | |
| 1114443810 | 11144438 | Fatigue | |
| 1114443810 | 11144438 | Musculoskeletal discomfort | |
| 1114443810 | 11144438 | Musculoskeletal pain | |
| 1114443810 | 11144438 | Pain | |
| 1114443810 | 11144438 | Pain in extremity | |
| 1114443810 | 11144438 | Sleep disorder | |
| 1114443810 | 11144438 | Upper limb fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 1114443810 | 11144438 | 1 | 201411 | 0 | ||
| 1114443810 | 11144438 | 3 | 201412 | 0 | ||
| 1114443810 | 11144438 | 4 | 201501 | 201511 | 0 | |
| 1114443810 | 11144438 | 5 | 20160209 | 0 | ||
| 1114443810 | 11144438 | 7 | 2008 | 0 | ||
| 1114443810 | 11144438 | 8 | 2014 | 0 | ||
| 1114443810 | 11144438 | 9 | 201401 | 0 | ||
| 1114443810 | 11144438 | 10 | 2014 | 0 | ||
| 1114443810 | 11144438 | 12 | 2015 | 0 | ||
| 1114443810 | 11144438 | 14 | 2014 | 0 | ||
| 1114443810 | 11144438 | 15 | 2015 | 0 | ||
| 1114443810 | 11144438 | 16 | 2016 | 0 | ||
| 1114443810 | 11144438 | 17 | 2016 | 0 | ||
| 1114443810 | 11144438 | 18 | 2015 | 0 | ||
| 1114443810 | 11144438 | 19 | 2016 | 0 | ||
| 1114443810 | 11144438 | 20 | 2010 | 0 | ||
| 1114443810 | 11144438 | 21 | 2012 | 0 | ||
| 1114443810 | 11144438 | 23 | 2010 | 0 |